SOD1 and inflammatory bowel disease: A previous study has demonstrated that inflammatory bowel disease (IBD) is attenuated by treatment with Tt-SOD, which is possibly due to decreased SOD activity and attenuated neutrophil infiltration in IBD animal models [21].